1. Asia investment keeps Carl Zeiss Meditec on track

    Asia investment keeps Carl Zeiss Meditec on track

    Carl Zeiss Meditec has posted a solid start to its latest financial year, with the German biomedical optics giant saying that its recent investments in Asia are “really paying off”. The Jena-headquartered company posted sales of €219 million for the first quarter of its financial year 2012/2013, up 4% on last year’s figure. Earnings before interest and tax (EBIT) also jumped more than 10% to €31.2 million as the firm’s profit margin widened. But as CEO Ludwin Monz explained, the underlying story was one of very different trends in different sectors, with the company benefiting from ...

    Read Full Article

    Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources, Velocimetry
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Quotes

    1. We assume that the US elections and the resulting insecure political decisions for the healthcare sector and the change of model in the diagnosis segment caused reserved purchasing behavior among our customers, in particular among physicians in private practice.
      By Ludwin Monz
  3. Topics Mentioned